Hematology TimesDeep molecular responses achievable in AML pts treated with gilteritinibJune 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMajority of AML patients do not receive recommended molecular genetic testingJune 11, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesEU label for nilotinib now includes info on stopping therapyJune 9, 2017Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesDasatinib potentially a new SOC for children with CML-CPJune 9, 2017Leukemia, Myelodysplasia, TransplantationPediatricsCML
Hematology TimesPembrolizumab enhances CAR T-cell persistence in relapsed ALLJune 8, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesAddition of ublituximab to ibrutinib improves response in r/r CLLJune 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesCAR T cells elicit durable, potent responses in kids with EM relapse of ALLJune 5, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesAzacitidine alone comparable to AZA combos for most MDS patientsJune 5, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesSevere health conditions decrease among childhood cancer survivorsJune 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDifferences emerge in new guidelines for managing FN in kidsJune 3, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsTransplantationAMLALLAggressive Lymphomas
Hematology TimesAuthority on hematologic malignancies diesMay 31, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic SyndromeCML
Hematology NewsiFCG achieves high MRD-negative remission in untreated CLLMay 30, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC grants drug orphan designation for AMLMay 26, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEMA recommends orphan designation for AML drugMay 25, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesWhy fewer blood cancer patients receive hospice careMay 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAggressive Lymphomas
